Stay updated on RENEW Trial: Dry Eye Disease Clinical Trial
Sign up to get notified when there's something new on the RENEW Trial: Dry Eye Disease Clinical Trial page.

Latest updates to the RENEW Trial: Dry Eye Disease Clinical Trial page
- Check2 days agoChange DetectedThe record presents details of the completed Phase 3 RENEW trial of reproxalap for dry eye disease, including its study design, participant criteria, treatment arms, and outcome measures. It also includes study history, results-related dates, and links to the protocol and statistical analysis plan.SummaryDifference44%

- Check9 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 error.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe page continues to display a 403 Forbidden error instead of the study record. The footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1; the page still shows a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study record content with a standard error screen. This prevents access to the study details.SummaryDifference17%

Stay in the know with updates to RENEW Trial: Dry Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RENEW Trial: Dry Eye Disease Clinical Trial page.